Emerging Agents in the Pipeline for Merkel Cell Carcinoma
3 Mga view
• 07/17/23
0
0
I-embed
administrator
Mga subscriber
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento